product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-Tie2 (Ser1119) Antibody
catalog :
4226
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse
application :
western blot, immunohistochemistry - frozen section
more info or order :
Cell Signaling Technology product webpage
citations: 2
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - frozen section; human; 1:1000; loading ...; fig 2h
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 5f
Jenny Zhou H, Qin L, Zhang H, Tang W, Ji W, He Y, et al. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nat Med. 2016;22:1033-1042 pubmed publisher
  • western blot; human; loading ...; fig 5a
Bachegowda L, Morrone K, Winski S, Mantzaris I, Bartenstein M, Ramachandra N, et al. Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia. Cancer Res. 2016;76:4841-4849 pubmed publisher
product information
SKU :
4226S
Product-Name :
Phospho-Tie2 (Ser1119) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H
Applications :
Western blot
Product-Category :
RTK
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
160
Host :
Rabbit
Target :
Tie2 (Ser1119) phosphate
Primary-Protein :
TIE2
Alt-Names :
Angiopoietin-1 receptor,CD202B,TEK,TEK tyrosine kinase, endothelial,TIE-2,TIE2,Tunica interna endothelial cell kinase,Tyrosine-protein kinase receptor TEK,Tyrosine-protein kinase receptor TIE-2,VMCM,VMCM1,hTIE2,p140 TEK,soluble TIE2 variant 1,soluble TIE2 variant 2
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.